Smalling Ralph 4
4 · GENELUX Corp · Filed Sep 3, 2025
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Smalling Ralph
Head of Regulatory
Transactions
- Award
Common Stock
2025-09-01+10,000→ 70,990 total - Disposition to Issuer
Stock Option (Right to Buy)
2025-09-01−8,333→ 0 totalExercise: $6.00Exp: 2030-09-23→ Common stock (8,333 underlying) - Award
Stock Option (Right to Buy)
2025-09-01+8,333→ 8,333 totalExercise: $3.33Exp: 2030-09-23→ Common stock (8,333 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common Stock upon vesting. The RSUs will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 12 equal quarterly (every 3 months) installments thereafter.
- [F2]The shares subject to the option vest as follows: 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter.
- [F3]The transactions reported herein reflect a one-time reduction of the exercise price of the stock option, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration date or the vesting schedule of the stock option.